Obesity

Ozempic Prescription Guide: Eligibility and Access

Ozempic (semaglutide) is a prescription medication initially approved for adults with type 2 diabetes to improve blood sugar control and reduce cardiovascular risks . While it is not officially approved for weight loss, its active ingredient, semaglutide, is recognized for significant weight reduction effects, particularly under the brand name Wegovy . The surge in demand for Ozempic has raised questions about eligibility, access, and alternatives for patients seeking treatment for obesity and related conditions .